Rinehart Joseph, Desebbe Olivier, Berna Antoine, Lam Isaac, Coeckelenbergh Sean, Cannesson Maxime, Joosten Alexandre
Department of Anesthesiology & Perioperative Care, University of California Irvine, 101 The City Drive South, Irvine, CA 92868, USA.
Department of Anesthesiology and Perioperative Medicine, Sauvegarde Clinic, Ramsay Santé, 69009 Lyon, France.
J Pers Med. 2022 Sep 21;12(10):1554. doi: 10.3390/jpm12101554.
Introduction: Vasopressor infusions are essential in treating and preventing intraoperative hypotension. Closed-loop vasopressor therapy outperforms clinicians when the target is set at a mean arterial pressure (MAP) baseline, but little is known on the performance metrics of closed-loop vasopressor infusions when systolic arterial pressure (SAP) is the controlled variable. Methods: Patients undergoing intermediate- to high-risk abdominal surgery were included in this prospective cohort feasibility study. All patients received norepinephrine infusion through a computer controlled closed-loop system that targeted SAP at 130 mmHg. The primary objective was to determine the percent of case time in hypotension or under target defined as SAP below 10% of the target (SAP < 117 mmHg). Secondary objectives were the percent of case time “above target” (SAP > 10% of the target or >143 mmHg) and “in target” (within 10% of the SAP target or SAP between 117 and 143 mmHg). Results: A total of 12 patients were included. The closed-loop system infused norepinephrine for a median of 94.6% (25−75th percentile: 90.0−98.0%) of case time. The percentage of case time in hypotension or under target was only 1.8% (0.9−3.6%). The percentages of case time “above target” and “in target” were 4.7% (3.2−7.5%) and 92.4% (90.1−96.3%), respectively. Conclusions: This closed-loop vasopressor system minimizes intraoperative hypotension and maintains SAP within 10% of the target range for >90% of the case time in patients undergoing intermediate- to high-risk abdominal surgery.
血管升压药输注对于治疗和预防术中低血压至关重要。当将目标设定为平均动脉压(MAP)基线时,闭环血管升压药治疗的效果优于临床医生,但对于以收缩压(SAP)作为控制变量时闭环血管升压药输注的性能指标知之甚少。方法:本前瞻性队列可行性研究纳入了接受中高危腹部手术的患者。所有患者通过计算机控制的闭环系统接受去甲肾上腺素输注,该系统将SAP目标设定为130 mmHg。主要目标是确定低血压或低于目标值(定义为SAP低于目标值的10%,即SAP < 117 mmHg)的病例时间百分比。次要目标是“高于目标值”(SAP > 目标值的10%或> 143 mmHg)和“在目标值范围内”(在SAP目标值的10%以内或SAP在117至143 mmHg之间)的病例时间百分比。结果:共纳入12例患者。闭环系统在94.6%(第25 - 75百分位数:90.0 - 98.0%)的病例时间内输注去甲肾上腺素。低血压或低于目标值的病例时间百分比仅为1.8%(0.9 - 3.6%)。“高于目标值”和“在目标值范围内”的病例时间百分比分别为4.7%(3.2 - 7.5%)和92.4%(90.1 - 96.3%)。结论:对于接受中高危腹部手术的患者,这种闭环血管升压药系统可将术中低血压降至最低,并在超过90%的病例时间内将SAP维持在目标范围的10%以内。